Monaco Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Monaco Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$455K	Sell	244,487 -174,316	-42%	-$287K	0.04%	47
2026 Q1	$678K	Sell	418,803 -10,000	-2%	-$16.4K	0.13%	61
2025 Q4	$866K	Sell	428,803 -31,197	-7%	-$72.9K	0.15%	66
2025 Q3	$980K	Hold	460,000	–	–	0.06%	66
2025 Q2	$938K	Sell	460,000 -11,908	-3%	-$19.4K	0.16%	70
2025 Q1	$628K	Buy	471,908 +175,290	+59%	+$373K	0.13%	62
2024 Q4	$786K	Sell	296,618 -31,274	-10%	-$99.3K	0.11%	62
2024 Q3	$597K	Buy	327,892 +15,263	+5%	+$28.7K	0.09%	64
2024 Q2	$519K	Hold	312,629	–	–	0.08%	56
2024 Q1	$710K	Sell	312,629 -65,847	-17%	-$141K	0.21%	45
2023 Q4	$749K	Buy	378,476 +959	+0.3%	+$1.47K	0.22%	59
2023 Q3	$491K	Buy	377,517 +140,000	+59%	+$220K	0.15%	62
2023 Q2	$385K	Buy	237,517 +58,183	+32%	+$114K	0.11%	59
2023 Q1	$382K	Buy	179,334 +14,334	+9%	+$43.8K	0.12%	60
2022 Q4	$611K	Sell	165,000 -766,400	-82%	-$1M	0.18%	60
2022 Q3	$693K	Hold	931,400	–	–	0.27%	50
2022 Q2	$724K	Buy	931,400 +840,500	+925%	+$627K	0.32%	46
2022 Q1	$82K	Buy	+90,900	New	+$305K	0.03%	47

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Monaco Asset Management's PRQR Position: Q2 2026 in Review

Monaco Asset Management reduced its ProQR Therapeutics (PRQR) stake by 42% in Q2 2026, selling an estimated $287K and leaving 244,487 shares worth $455K. The position accounts for 0.04% of the portfolio, ranked #47.

Monaco Asset Management first reported a position in PRQR in Q1 2022 and has held it in 18 quarters since. The position peaked at $980K in Q3 2025. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

Monaco Asset Management held 244,487 shares of ProQR Therapeutics worth $455K as of Q2 2026.
Monaco Asset Management sold 174,316 ProQR Therapeutics shares in Q2 2026, an estimated $287K.
ProQR Therapeutics made up 0.04% of Monaco Asset Management's portfolio in Q2 2026, its #47 holding.
Monaco Asset Management first reported a position in ProQR Therapeutics in Q1 2022 and has held it in 18 quarters since.
Monaco Asset Management's ProQR Therapeutics position peaked at $980K in Q3 2025.
70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.